Last updated: June 12, 2026
Suppliers for Dextrose 10% and Sodium Chloride 0.11% in Plastic Container (IV Fluids)
Dextrose 10% and sodium chloride 0.11% in plastic containers is typically supplied as an IV admixture-formulated electrolyte infusion under varying product strengths, container sizes, and labeling across manufacturers and distributors. Supplier coverage depends on geography, tender scope, and whether the product is marketed as a ready-to-use solution versus compounded by a contract manufacturer from separately sourced dextrose and sodium chloride.
Which companies supply dextrose 10% + sodium chloride 0.11% IV in plastic containers?
Dextrose-saline combination products are commonly sourced from large sterile injectables manufacturers that produce premixed IV solutions in plastic containers (usually polyolefin bags, depending on the market). In practice, the supplier roster is dominated by global generic sterile manufacturers plus regional distributors that win hospital group tenders.
Common supplier archetypes in IV premix saline-dextrose
- Sterile injectables manufacturers (global generics and contract manufacturing)
- Hospital supply distributors and group purchasing organizations (relabeling and tender fulfillment)
- Contract packagers that source sterile components and bottle/bag finished sterile products under the distributor brand
Container and presentation variants that affect “who supplies”
Even when the label strength matches, procurement often differs by:
- Plastic type (commonly polyolefin-based bags vs PVC-based systems in some regions)
- Bag size (typical IV solution sizes vary by country and formulary)
- Drug product labeling (different “sodium chloride” strength representations may appear due to rounding or different nominal formulations)
Because procurement systems may index by NDC/GTIN, container size, or trade name rather than by the formulation description alone, “supplier lists” must be built by matching the exact marketed product IDs.
How do you find the exact suppliers by NDC/GTIN for dextrose 10% + sodium chloride 0.11%?
Procurement accuracy for IV fluids depends on the product identifier. Suppliers for the same chemistry can change by:
- National Drug Code (NDC) and manufacturer labeler
- GTIN per presentation size
- Distributor tender contracts (same NDC may be supplied through multiple distributors)
What to search in supply systems
- NDC (preferred for US tender and pharmacy procurement systems)
- GTIN (preferred for EU/UK catalog and logistics)
- Product name string (include “dextrose 10%,” “sodium chloride 0.11%,” “plastic container,” and bag size)
What changes supplier availability
- Shortages and lot release disruptions
- Tender awarding cycles
- Contract manufacturing transitions (site changes within the same brand owner)
Which suppliers are strongest for hospital tender delivery of premixed dextrose-saline?
The strongest suppliers for hospital tenders are those that can consistently deliver across:
- Multiple bag sizes
- Stable lead times
- Broad distribution coverage to group purchasing organizations
Evaluation criteria used in tenders (practical)
- Sterile production capacity for IV premixes
- Quality system maturity and inspection history
- Ability to supply without substitution
- Documentation for pharmacy use (USP compliance statements, container material, osmolality references where applicable)
When does generic or alternative sourcing become available for dextrose-saline 10%/0.11% in plastic?
Dextrose and sodium chloride IV solutions are generally not patent-protected as small-molecule bulk ingredients in the way therapeutics are. Supplier shifts typically come from:
- Manufacturing capacity additions or closures
- Regulatory approvals and reclassifications
- Tender-driven substitutions
Typical triggers for supplier rebalancing
- New package sizes added to a formulary
- Contract manufacturer transitions
- Distribution agreements ending or being renegotiated
What regulatory status affects suppliers of dextrose 10% + sodium chloride 0.11% solutions?
Regulatory status affects whether a supplier can legally market and ship the product in a given market.
US lens (FDA)
- IV solutions are regulated as approved drug products and must be manufactured under current Good Manufacturing Practice.
- To qualify for US distribution, suppliers must have the correct approved product listing tied to the NDC.
EU/UK lens (EMA/AH and national authorizations)
- Market authorization is required per presentation.
- Variations in plastic container type and presentation size can be tied to specific approvals.
What formulation and container specs limit interchangeable supply?
Even when the active strengths look identical, interchangeability can fail if:
- Osmolality differs beyond accepted ranges
- Electrolyte labeling differs (sodium chloride expressed as nominal vs rounded)
- Container material differs and affects compatibility policies
- Bag size differs from the formulary requirement
Procurement-impacting attributes to match
- Sodium content and label strength expression
- Bag volume and overwrap specs
- Container material
- Any added components (if present in some “equivalent” listings)
How do suppliers differ for compounding vs ready-to-use premix?
Some facilities source ready-to-use IV premixes; others use compounding pharmacies to create dextrose-saline solutions from components. Supplier dynamics differ:
Ready-to-use premix suppliers
- Provide standardized bag products
- Win tenders for convenience and lower labor burden
Compounding suppliers (contract manufacturers or in-house pharmacies)
- Depend on bulk dextrose and sodium chloride sourcing
- Produce consistent electrolyte profiles if compounding SOPs are controlled
- Pose different QA and release testing workflows
Competitive landscape: who supplies IV dextrose-saline in plastic containers at scale?
The competitive landscape for IV premixed electrolyte solutions is usually anchored by:
- Large sterile injectables manufacturers with established IV bag lines
- Companies with regional distribution advantages
- Distributor-led fulfillment models where multiple manufacturers supply a hospital group through bidding and allocation
What you should expect in the market
- Multiple NDC/labeler options under the same “dextrose + sodium chloride” concept
- Distributor consolidation that makes it look like “fewer suppliers” even when multiple manufacturers exist upstream
Key supplier mapping table (what must be populated to make it decision-grade)
A decision-grade supplier list must be built by exact product identifiers. The table below is the framework procurement and contracting teams use; it must be filled using the specific NDC/GTIN and market (country) for the target hospital network.
| Country/Market |
Product identifier (NDC/GTIN) |
Trade/Labeler name |
Manufacturer (site) |
Presentation (bag size) |
Container type (plastic) |
Typical tender suppliers (distributor layer) |
| US |
[NDC] |
[Labeler] |
[Manufacturer] |
[e.g., 500 mL/1000 mL] |
[Polyolefin/PVC] |
[Distributor names from contract] |
| EU/UK |
[GTIN] |
[Brand] |
[MAH/manufacturer] |
[mL] |
[Bag material] |
[National wholesaler(s)] |
Key Takeaways
- Supplier availability for “dextrose 10% and sodium chloride 0.11% in plastic container” is driven by the exact marketed product identifier (NDC/GTIN), bag size, and container type, not just the formulation description.
- Large sterile injectables manufacturers and tender-focused distributors dominate hospital supply.
- Interchangeability breaks when bag size, plastic container material, or sodium labeling conventions differ.
- Any defensible supplier list for contracting or substitution risk management must be grounded in exact product identifiers tied to the target market.
FAQs
What NDC matches dextrose 10% and sodium chloride 0.11% in plastic container?
NDC matching must be done per country and per bag size because labeler and presentation changes create different NDCs.
Can I substitute a different sodium chloride concentration with the same dextrose 10%?
No. Substitution risk is driven by sodium content, electrolyte labeling conventions, and facility compatibility policies with IV fluids.
Do ready-to-use suppliers differ from compounding suppliers for this mixture?
Yes. Ready-to-use premix suppliers provide standardized sterile bags; compounding relies on bulk ingredient sourcing and controlled manufacturing release.
Which container types are used for IV dextrose-saline plastic bags?
Market-specific plastic systems are used, commonly polyolefin bags in many jurisdictions, but procurement must match the approved container type for the specific product listing.
How do shortages usually impact dextrose-saline premix supply?
Shortages typically force allocation changes at the distributor level and substitution only if an approved equivalent product in the same presentation and identifier family is available.
References
- FDA Orange Book. FDA. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- FDA Drug Shortages. FDA. https://www.accessdata.fda.gov/scripts/drugshortages/
- FDA NDC Directory. FDA. https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
